Concepedia
Statistics
Publications
7
Citations
173
H-Index
Active since
2016
Affiliations
ABL Bio (South Korea)(Current)
National Research Council Canada
Jin-Hyung Ahn is an author at ABL Bio (South Korea) specializing in oncology, molecular oncology, and medicine.
Publications per year
2016–2025
Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis
Dongheon Lee, Dongin Kim, Yu Bin Choi et al. · mAbs · 2016 · 45 citations · Full text
Medicine, Oncology, Pharmacology +17
ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
Dong-Hoon Yeom, Yo-Seob Lee, Ilhwan Ryu et al. · International Journal of Molecular Sciences · 2020 · 36 citations · Full text
Medicine, Oncology, Pharmacology +16
Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier
Jung-Won Shin, Sungwon An, Dongin Kim et al. · Cell Reports Methods · 2022 · 33 citations · Full text
Pharmacy, Molecular Biology, Pharmaceutics +17
Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer
Da-Hyun Kim, Seul Lee, Hyeok-Gu Kang et al. · BMB Reports · 2020 · 19 citations · Full text
A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies
Sungwon An, John J. McInnis, Dongin Kim et al. · npj Parkinson s Disease · 2025 · 15 citations · Full text
Life Sciences, Immunology, Neuroscience +17
1–5 of 7